Roche Makes Early Headway With Pharmaco-Diagnostics
Executive Summary
As discussion of personalized medicine transitions from being a hot new topic to a predominant mentality for R&D, a lot of focus is on Roche to see how the diversified company leverages its dual footholds in the pharmaceutical and diagnostics worlds
You may also be interested in...
Companion Dx Pioneers Test Variety Of Business Models
Regulatory environment opens up, but alliances with Pharma have yet to take off.
Drug, Diagnostic Firms Should Partner, Not Merge, To Personalize Medicine
The drug and diagnostic industries should partner, not merge, to develop companion products, according to a diagnostics industry representative on a recent Personalized Medicine Coalition conference panel
Drug, Diagnostic Firms Should Partner, Not Merge, To Personalize Medicine
The drug and diagnostic industries should partner, not merge, to develop companion products, according to a diagnostics industry representative on a recent Personalized Medicine Coalition conference panel